Price target
110.050.00 0.00%
The 25 analysts offering 1 year price forecasts for 0HNC have a max estimate of — and a min estimate of —.
Analyst rating
Based on 30 analysts giving stock ratings to 0HNC in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
0HNC EPS for the last quarter is 0.46 USD despite the estimation of 0.31 USD. In the next quarter EPS is expected to reach 0.33 USD. Track more of BIOMARIN PHARMACEUTICAL COM STK USD0.001 financials and stay on top of what is up with the company.
In the next quarter BIOMARIN PHARMACEUTICAL COM STK USD0.001 revenue is expected to reach 660.59 M USD. Check out BIOMARIN PHARMACEUTICAL COM STK USD0.001 revenue and earnings and make informed decisions.
According to analysts, 0HNC price target is 110.05 USD with a max estimate of 140.00 USD and a min estimate of 80.00 USD. Check if this forecast comes true in a year, meanwhile watch BIOMARIN PHARMACEUTICAL COM STK USD0.001 stock price chart and keep track of the current situation with 0HNC news and stock market news.
We've gathered opinions of 30 analysts rating 0HNC stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.